Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:2.1.1.37 (DNA methyltransferase)
 4,983 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Sodium selenite is a good inducer of hemoglobin production in Friend erythroleukemic cells (FELC). At a concentration of 20 microM 70-80% of the cells produce hemoglobin and the DNA is hypomethylated. What is the mechanism for sodium selenite alteration of the DNA methylation pattern? Experiments with methionine adenosyltransferase (the enzyme that synthesizes adenosylmethionine) showed little effect of selenite on the activity of this enzyme in vitro or in vivo. Therefore, FELC are able to synthesize S-adenosylmethionine in the presence of sodium selenite. When sodium selenite was added to an in vitro assay for DNA methylase, the enzyme was non-competitively inhibited by 80% at 20 microM selenite with a Ki of 6 microM. DNA methylase isolated from control and selenite-treated FELC was purified through a DEAE-Sephacel column and no difference in activity was found. In the presence of selenite, DNA methylase is very sensitive to selenite inhibition, but removal of the selenite restores activity. However, DNA synthesized by FELC grown in the presence of selenite (no DNA methylase activity) was found to be hypomethylated. These results suggest that DNA methylase activity is inhibited in FELC grown in the presence of sodium selenite.
Carcinogenesis 1986 Dec
PMID:A study of the mechanism of selenite-induced hypomethylated DNA and differentiation of Friend erythroleukemic cells. 346 78

To clarify the involvement of O6-methylguanine (O6-MeG) in mutagenesis, we isolated N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-resistant cells, MR10-1 from HeLa S3 mer- cells. MR10-1 cells were 40 times more resistant to MNNG than the parental cells. MR10-1 cells were also significantly more resistant to N-methyl-N-nitrosourea and slightly more resistant to methyl methanesulfonate and dimethyl sulfate than parental cells. However, we found that MR10-1 cells had still little O6-MeG-DNA methyltransferase activity and were sensitive to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl- 3-(2-chloroethyl)-3-nitrosourea hydrochloride, like HeLa mer- cells, thereby showing that MR10-1 cells are still mer-. When induced 6-thioguanine (6TG)-resistant colonies were plotted as a function of the corresponding percentage survival, the resistant colonies of MR10-1 cells were induced much more frequently than in the case of HeLa mer- cells. However, induction of 6TG-resistant cells in both cell lines did not differ significantly in terms of mutant cells per 0.1 microM MNNG. On the contrary, MR10-1 cells (mer-) and two HeLa S3 mer+ cells lines differed in the induction of mutation as a function of MNNG concentration. The HeLa mer+ cell lines were not mutable, while MR10-1 cells were highly mutable. These above results clearly show that the HeLa mer- cell has at least two defects in the repair of the alkylated adducts which are related to cell killing and mutation, and also suggest that O6-MeG is involved in the induction of mutation.
Carcinogenesis 1987 Aug
PMID:N-methyl-N'-nitro-N-nitrosoguanidine-resistant HeLa S3 cells still have little O6-methylguanine-DNA methyltransferase activity and are hypermutable by alkylating agents. 360 93

O6-Methylguanine DNA methyltransferase (O6-MT) is considered to play an important role in the repair of alkylating carcinogen-induced lesions in a wide range of mammalian species. Fish are used widely in cancer research, one advantage being their high sensitivity to a variety of alkylating agents. To throw light on the mechanisms of DNA repair in the hitherto uninvestigated fish group, O6-MT activity was measured in liver from eight fish species belonging to six classes. Levels of O6-MT activity comparable with mouse values were found in liver of Japanese medaka (Oryzias latipes). Relatively low, but appreciable, levels of O6-MT activity were also observed in the other seven species examined. No adaptive increase in enzyme activity could be established in liver of rainbow trout following chronic dimethylnitrosamine pretreatment.
Carcinogenesis 1987 Aug
PMID:O6-methylguanine DNA methyltransferase activity in liver from various fish species. 360 94

Mer- human cells, which lack O6-methylguanine DNA methyltransferase activity, are extremely sensitive to alkylation induced killing, mutation and sister chromatid exchange. We have analyzed a Mer+, a Mer-, and a Mer- revertant HeLa cell line and found that the methyltransferase deficiency correlates with increased levels of mutation and sister chromatid exchange, but does not correlate with increased killing of Mer- HeLa cells by alkylating agents. Furthermore, we show that HeLa Mer- cells repair N-3-methylguanine and N-3-methyladenine just as efficiently as HeLa Mer+ cells.
Carcinogenesis 1987 Feb
PMID:DNA alkylation repair and the induction of cell death and sister chromatid exchange in human cells. 380 5

The activity of de novo DNA (cytosine-5-)-methyltransferase (DNA methylase) in various rat tissues after administration of a single dose of N-methyl-N-nitrosourea (MNU) has been analyzed. The total and specific activities of the DNA methylase of the brain, where tumor induction is important, are increased. In kidney, the DNA methylase activity first increases up to 16 h and decreases afterwards. Liver DNA methylase activity does not change. This organ is not susceptible to MNU induced cancers. Because organs in which the DNA methylase activity is high or increased after MNU are more prone to carcinogenesis by this compound, we argue that there is a relationship between the effects of MNU and DNA methylase activity.
 ...
PMID:Changes in de novo DNA (cytosine-5-)-methyltransferase activity in oncogenically susceptible rat target tissues induced by N-methyl-N-nitrosourea. 394 88

The Burkitt's lymphoma cell line Raji has a Mex+ phenotype. It is more resistant to killing by alkylating agents than a sub line (Raji TK-) which is Mex-. A reduction in O6-methylguanine (O6MeG)-DNA methyltransferase can be brought about by growing Raji cells in the presence of free O6MeG. The depletion in enzyme activity is specific and reversible; removal of O6MeG from the medium results in the restoration of methyltransferase activity within 4 h. Raji cells, in which methyltransferase has been reduced by this treatment to below detectable levels, are not sensitised to killing by N-methyl-N'-nitro-N-nitrosoguanidine or the cross-linking nitrosoureas, 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-1-nitrosourea. This implies that adducts at the O6 atom of guanine in DNA are not potentially cytotoxic lesions. Secondly, it suggests that a defect other than the lack of methyltransferase is responsible for the sensitivity of Mex- cells to killing by alkylating agents.
Carcinogenesis 1985 May
PMID:The cytotoxic and mutagenic effects of alkylating agents on human lymphoid cells are caused by different DNA lesions. 400 64

DNA methyltransferase (DMase) was purified 700- and 1002-fold from normal rat liver and transplantable hepatocellular carcinoma 252 (THC 252) nuclei, respectively, using a four-step procedure that included chromatography on phosphocellulose, hydroxylapatite, DEAE-Sephacel and gel filtration on AcA 34. The enzymes had identical characteristics: pI = 7.4-7.6; Mr = 280 000 by gel filtration; preference for methylating double-stranded over single-stranded DNA and hemimethylated over unmethylated DNA templates; and apparent km of 10 microM for dinucleotide units in poly(dC-dG) and 0.5 microM for S-adenosylmethionine (SAM). Thermal inactivation profiles and sulfhydryl group alkylation inhibition curves for fraction III produced very similar single-transition curves, suggesting the presence of a single-functional enzyme species that is indistinguishable between normal and tumor tissue. Single-value Michaelis-Menten kinetics were obtained for fraction IV enzymes with respect to the concentration of SAM and dinucleotide units in poly(dC-dG), suggesting the absence of isozymic or multiple forms of DMase in normal and malignant liver tissues.
Carcinogenesis 1985 Jun
PMID:Indistinguishable physical and catalytic properties of DNA methyltransferase from normal rat liver and a transplantable rat hepatocellular carcinoma. 400 74

The status of DNA methylation, as measured by the 5-methylcytosine content of nuclear DNA, was examined in normal livers and in chemically induced or spontaneous primary hepatocellular carcinoma (PHC) arising in three strains of mice. The DNA from spontaneous tumors of genetic origin in C3H mice and also from acetylaminofluorene, chlordane, or 3'-methyl-4-dimethylaminoazobenzene-induced tumors in C57Bl and B6C3 mice was undermethylated compared to the levels in background and normal liver samples. The DNA methylase activities from normal liver, background liver, and PHC were assayed in C3H mice to determine whether the observed genomic undermethylation is related to a dysfunction of this enzyme and were compared to the rates of DNA synthesis in these tissues. Since DNA methylase levels from tumor nuclei were elevated compared to background, it is concluded that the undermethylation found in the tumor genomes of this system is not due to inactivation nor a significant deficiency of the activity of this enzyme relative to the demand in tumors for methylation of de novo synthesized DNA.
Carcinogenesis 1981
PMID:DNA methylation and methylase levels in normal and malignant mouse hepatic tissues. 627 14

Highly purified DNA methyltransferase from human placenta methylates hemimethylated and 5-methylcytosine-free DNA substrates suggesting that one enzyme molecule may exercise both, the maintenance and de novo activities. Modification of these methyl accepting polymers with (+/-)-r-7,t-8-dihydroxy-t-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene, anti (BPDE) interferes with the methylation reaction, and this inhibition is proportional to the degree of BPDE-modification. This indicates that BPDE - DNA adducts affect both the maintenance and the de novo DNA methyltransferase activities. The mechanism responsible for such inhibition is related neither to interference of BPDE - DNA adducts with the initial binding of the enzyme to DNA nor with the processive mode of action of the enzyme on the modified DNA template. More likely, the BPDE - DNA adducts inhibit the transmethylation reaction directly at the sites of modification.
Carcinogenesis 1984 Jul
PMID:Impaired enzymatic methylation of BPDE-modified DNA. 642 67

As a step towards understanding the significance of DNA repair enzymes in the protection against genotoxic and carcinogenic agents, we have examined the activity of O6-methyl-guanine-DNA methyltransferase and uracil-DNA glycosylase in adult human liver, stomach, small intestine and colon. Liver had on average a 5- to 8-fold higher activity of O6-MeG-DNA methyltransferase than the other organs and showed about an 8-fold inter-individual variation. In colon and small intestine an even larger inter-individual variation was observed (10- and 40-fold, respectively). In two colon tumors examined the activity of O6-MeG-DNA methyltransferase was several fold higher than in non-neoplastic colon mucosa from the same individuals, while uracil-DNA glycosylase activity was essentially equal in neoplastic and non-neoplastic tissues. O6-MeG-DNA methyltransferase activities in two gastric tumors examined were not higher than in average non-neoplastic tissue. In general the activity of uracil-DNA glycosylase did not correlate with the O6-MeG-DNA methyltransferase activity. The inter-individual variation of this enzyme in the activity was only 3-fold in liver and normal stomach, but varied 5.5 and 60-fold in colon and small intestine, respectively. In conclusion, we have found that O6-MeG-DNA methyltransferase as well as uracil-DNA glycosylase activity vary considerably between different tissues as well as between different individuals. Whether this variation has a genetic basis or reflects variation in 'life style' is not known.
Carcinogenesis 1983 Dec
PMID:Interindividual variation in the activity of O6-methyl guanine-DNA methyltransferase and uracil-DNA glycosylase in human organs. 665 69


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>